Dr. John Diaz, MD
Claim this profileMiami Cancer Institute at Baptist Health, Inc.
Area of expertise
Ovarian Cancer
John Diaz, MD has run 6 trials for Ovarian Cancer. Some of their research focus areas include:
Fallopian Tube Cancer
John Diaz, MD has run 3 trials for Fallopian Tube Cancer. Some of their research focus areas include:
Affiliated Hospitals
Miami Cancer Institute
South Miami Hospital
Clinical Trials John Diaz, MD is currently running
Robotic vs Open Hysterectomy
for Cervical Cancer
This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
Recruiting
1 award
N/A
8 criteria
Heated Chemotherapy + Niraparib
for Ovarian Cancer
Patients will be registered prior to, during or at the completion of neoadjuvant chemotherapy (Paclitaxel 175 mg/m2 IV over 3 hours and Carboplatin AUC 6 IV on Day 1 every 21 days for 3-4 cycles). Registered patients who progress during neoadjuvant chemotherapy will not be eligible for iCRS and will be removed from the study. Following completion of neoadjuvant chemotherapy, interval cytoreductive surgery (iCRS) will be performed in the usual fashion in both arms. Patients will be randomized at the time of iCRS (iCRS must achieve no gross residual disease or no disease \>1.0 cm in largest diameter) to receive HIPEC or no HIPEC. Patients randomized to HIPEC (Arm A) will receive a single dose of cisplatin (100mg/m2 IP over 90 minutes at 42 C) as HIPEC. After postoperative recovery patients will receive standard post-operative platinum-based combination chemotherapy. Patients randomized to surgery only (Arm B) will receive postoperative standard chemotherapy after recovery from surgery. Both groups will receive an additional 2-3 cycles of platinum-based combination chemotherapy per institutional standard (Paclitaxel 175 mg/m2 IV over 3 hours and Carboplatin AUC 6 IV on Day 1 every 21 days for 2-3 cycles) for a maximum total of 6 cycles of chemotherapy (neoadjuvant plus post-operative cycles) followed by niraparib individualized dosing until progression or 36 months (if no evidence of disease).
Recruiting
2 awards
Phase 3
More about John Diaz, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments John Diaz, MD has experience with
- Niraparib
- Olaparib
- Pembrolizumab
- Defactinib
- Avutometinib (VS-6766)
- STRO-002
Breakdown of trials John Diaz, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Cervical Cancer
Peritoneal Cancer
Ovarian Serous Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Diaz, MD specialize in?
John Diaz, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is John Diaz, MD currently recruiting for clinical trials?
Yes, John Diaz, MD is currently recruiting for 2 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that John Diaz, MD has studied deeply?
Yes, John Diaz, MD has studied treatments such as Niraparib, Olaparib, Pembrolizumab.
What is the best way to schedule an appointment with John Diaz, MD?
Apply for one of the trials that John Diaz, MD is conducting.
What is the office address of John Diaz, MD?
The office of John Diaz, MD is located at: Miami Cancer Institute at Baptist Health, Inc., Miami, Florida 33176 United States. This is the address for their practice at the Miami Cancer Institute at Baptist Health, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.